1202389-15-8

Basic information

• Product Name: 1-(2,5-dimethyl-4-nitrophenyl)-3-(dimethylamino)but-2-en-1-one
• Synonyms: 1-(2,5-dimethyl-4-nitrophenyl)-3-(dimethylamino)but-2-en-1-one
• CAS NO: 1202389-15-8
• Molecular Weight: 262.309
• Mol File: 1202389-15-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-(2,5-dimethyl-4-nitrophenyl)-3-(dimethylamino)but-2-en-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2,5-dimethyl-4-nitrophenyl)-3-(dimethylamino)but-2-en-1-one(1202389-15-8)
• EPA Substance Registry System: 1-(2,5-dimethyl-4-nitrophenyl)-3-(dimethylamino)but-2-en-1-one(1202389-15-8)

Safety Data

• Hazardous Substances Data: 1202389-15-8(Hazardous Substances Data)

Upstream product

• 15540-81-5 1-bromo-2,5-dimethyl-4-nitrobenzene 
• 18871-66-4 N,N-dimethylacetamide dimethyl acetal 
• 1202389-14-7 1-(2,5-dimethyl-4-nitrophenyl)ethanone 

Downstream Products

• 1202389-16-9 5-(2,5-dimethyl-4-nitrophenyl)-3-methylisoxazole 
• 1202389-21-6 5-(2,5-dimethyl-4-nitrophenyl)-3-methylpyrazol 
• 1202389-13-6 2,5-dimethyl-4-(3-methylisoxazol-5-yl)aniline 
• 1202389-20-5 2,5-dimethyl-4-(3-methyl-1H-pyrazol-5-yl)aniline 

Relevant articles and documents

COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS

The invention provides novel pyrimidine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of insulin-like growth factor (IGF-1R) or analplastic lymphoma kinase (ALK).